Expression of special AT-rich sequence-binding protein mRNA and its clinicopathological significance in non-small cell lung cancer.
- Author:
Lai-Yong ZHOU
1
;
Fang LIU
;
Jian TONG
;
Qun-Qing CHEN
;
Fu-Wei ZHANG
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Aged; Carcinoma, Non-Small-Cell Lung; genetics; metabolism; pathology; Female; Humans; Lung Neoplasms; genetics; metabolism; pathology; Lymphatic Metastasis; Male; Matrix Attachment Region Binding Proteins; genetics; metabolism; Middle Aged; Prognosis; RNA, Messenger; genetics; metabolism; Reverse Transcriptase Polymerase Chain Reaction; methods
- From: Journal of Southern Medical University 2009;29(3):534-537
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo detect the expression of AT-rich sequence-binding protein (SATB1) mRNA in non-small cell lung cancer (NSCLC) and explore the role of SATB1 in the development of NSCLC.
METHODSThe total RNA was extracted from NSCLC tissues and normal lung tissues and reverse transcribed into cDNA. Real-time fluorescence quantitative RT-PCR was performed for detecting the expression of SATB1 mRNA these tissues.
RESULTSThe expression of SATB1 mRNA was 13-fold higher in NSCLC tissues than in normal lung tissues (P<0.001), and in metastatic and nonmetastatic NSCLC, the expression was 23.63 and 5.57 folds that in normal lung tissues, respectively.
CONCLUSIONSATB1 mRNA expression might be associated with the development and lymph node metastasis of NSCLC and may potentially used as an indicator for predicting the prognosis of NSCLC.
